- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有217家主力机构披露2025-06-30报告期持股数据，持仓量总计7.52亿股，占流通A股64.98%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为15.11元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为15.11元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.11","date":1762329216,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.11.06","stock":"0.33","trade":"-0.47","ind":"1.73"},{"date":"2025.11.05","stock":"0.47","trade":"0.13","ind":"0.37"},{"date":"2025.11.04","stock":"-1.96","trade":"-1.91","ind":"-1.71"},{"date":"2025.11.03","stock":"-1.42","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"1.30","trade":"3.64","ind":"-1.14"},{"date":"2025.10.30","stock":"-2.11","trade":"-1.21","ind":"-1.16"},{"date":"2025.10.29","stock":"1.42","trade":"0.27","ind":"1.95"},{"date":"2025.10.28","stock":"-0.90","trade":"-0.37","ind":"-0.44"},{"date":"2025.10.27","stock":"1.63","trade":"0.79","ind":"1.51"},{"date":"2025.10.24","stock":"0.79","trade":"-0.38","ind":"2.02"},{"date":"2025.10.23","stock":"0.13","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"-5.41","trade":"0.67","ind":"-0.62"},{"date":"2025.10.21","stock":"0.63","trade":"1.33","ind":"2.06"},{"date":"2025.10.20","stock":"0.25","trade":"0.37","ind":"0.98"},{"date":"2025.10.17","stock":"-1.97","trade":"-1.01","ind":"-3.04"},{"date":"2025.10.16","stock":"-0.06","trade":"0.19","ind":"-0.25"},{"date":"2025.10.15","stock":"1.75","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"1.08","trade":"-1.22","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.86","trade":"-0.84","ind":"-0.93"},{"date":"2025.10.10","stock":"-1.10","trade":"-0.24","ind":"-2.70"},{"date":"2025.10.09","stock":"-0.55","trade":"-0.39","ind":"1.47"}]
普洛药业,深证成指,化学制药指数
压力支撑
该股压力位为15.10元，支撑位为14.98元。
[{"text":"\u538b\u529b\u4f4d","value":"15.10","date":1762358400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.98","date":1762358400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了7%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月06日 20:30
| 机构今日流向(万元) | -1625.72 | 机构5日流向(万元) | -1706.01 |
| 机构10日流向(万元) | -7776.34 | 机构20日流向(万元) | -19352.37 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少3947.67万股，其中基金净减仓50家，主力净减仓57家，请投资者中长期谨慎为宜。
截止2025-06-30，共217家主力机构（基金209家，一般法人6家，社保基金1家，保险公司1家），持仓量总计75243.44万股，占流通A股64.98%
其中，基金持仓与2024-12-31相比：
增仓：43家 ，增持 2503.19万股
减仓：93家 ，减持 743.47万股
新出现在主力名单中：61家 ，持有1068.44万股
从主力名单中消失：118家 ，原持有6573.55万股
其中，基金持仓与2024-12-31相比：
增仓：43家 ，增持 2503.19万股
减仓：93家 ，减持 743.47万股
新出现在主力名单中：61家 ，持有1068.44万股
从主力名单中消失：118家 ，原持有6573.55万股
消息面诊股
诊断结果：5.9消息面打败了8%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 普洛药业：11月5日获融资买入1016.94万元
2025-11-06 - 普洛药业：11月4日获融资买入1912.20万元
2025-11-05 - 普洛药业：公司会在回购期限内如期完成本次回购
2025-11-04 - 2025中国原料药行业“十五五”规划期竞争格局发展
2025-11-04 - 普洛药业：公司计划未来两年基本完成低毛利相关业务的
2025-11-04 - 普洛药业：公司在抗生素原料药方面具有较强的技术工艺
2025-11-04 - 普洛药业：第十一批集采相较于第十批集采的价格方面有
2025-11-04 - 普洛药业：公司拥有奥司他韦等多种可用于治疗流感的药
2025-11-04 - 净值依然在水下！刚刚，知名基金经理徐彦完成了建仓
2025-11-04 - 普洛药业：11月3日获融资买入1976.06万元
2025-11-04
消息列表
| 一般消息 | 高管变动 | 委员会变更 | 2025-09-08 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-20 |
| 利好 | 分红转增 | 10派3.4835元(含税) | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-18 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-03-28 |
| 利好 | 分红转增 | 10派3.560569元(含税) | 2025-03-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了74%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.11.06","price":"1.73","value":"-0.47"},{"date":"2025.11.05","price":"0.37","value":"0.13"},{"date":"2025.11.04","price":"-1.71","value":"-1.91"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"3.64"},{"date":"2025.10.30","price":"-1.16","value":"-1.21"},{"date":"2025.10.29","price":"1.95","value":"0.27"},{"date":"2025.10.28","price":"-0.44","value":"-0.37"},{"date":"2025.10.27","price":"1.51","value":"0.79"},{"date":"2025.10.24","price":"2.02","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"},{"date":"2025.10.21","price":"2.06","value":"1.33"},{"date":"2025.10.20","price":"0.98","value":"0.37"},{"date":"2025.10.17","price":"-3.04","value":"-1.01"},{"date":"2025.10.16","price":"-0.25","value":"0.19"},{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.22"},{"date":"2025.10.13","price":"-0.93","value":"-0.84"},{"date":"2025.10.10","price":"-2.70","value":"-0.24"},{"date":"2025.10.09","price":"1.47","value":"-0.39"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 亚太药业 | 49.74% | 19.83% | 6.1分 |
| 2 | 宏源药业 | 36.03% | 9.28% | 5.4分 |
| 3 | 康芝药业 | 32.61% | 22.45% | 6.3分 |
| 4 | 多瑞医药 | 31.83% | 0.61% | 5.1分 |
| 5 | *ST景峰 | 28.67% | 4.66% | 5.2分 |
| 6 | 金石亚药 | 20.23% | 8.98% | 5.8分 |
| 8 | 亨迪药业 | 17.79% | 5.43% | 4.3分 |
| 10 | 广生堂 | 14.11% | -1.36% | 4.9分 |
| 12 | 富祥药业 | 13.37% | 10.81% | 6.0分 |
| 14 | 海南海药 | 11.90% | 3.74% | 6.2分 |
| 16 | 莱美药业 | 11.27% | 7.24% | 5.8分 |
| 18 | 东亚药业 | 10.31% | 4.80% | 6.0分 |
| 20 | 华特达因 | 9.20% | 2.37% | 5.8分 |
| 22 | 民生健康 | 8.58% | 4.48% | 6.0分 |
| 24 | 赛分科技 | 8.39% | -2.79% | 6.0分 |
| 26 | 哈三联 | 8.31% | 2.57% | 4.8分 |
| 28 | 誉衡药业 | 7.67% | 4.01% | 6.4分 |
| 30 | 前沿生物 | 7.33% | 5.93% | 5.8分 |
| 32 | 海翔药业 | 6.84% | 13.22% | 6.0分 |
| 34 | 神奇制药 | 6.72% | 2.52% | 5.9分 |
| 36 | - | 6.26% | 0.26% | 分 |
| 38 | 山河药辅 | 6.01% | -0.65% | 4.5分 |
| 40 | 威尔药业 | 5.60% | 2.78% | 7.1分 |
| 42 | 莎普爱思 | 5.49% | 0.75% | 5.6分 |
| 44 | - | 5.28% | -2.38% | 分 |
| 46 | 丰原药业 | 5.12% | 3.52% | 5.7分 |
| 48 | 灵康药业 | 5.01% | 3.47% | 6.0分 |
| 50 | 德展健康 | 4.85% | 9.13% | 5.9分 |
| 52 | 溢多利 | 4.73% | 4.11% | 5.0分 |
| 54 | 鲁抗医药 | 4.40% | 3.03% | 5.9分 |
| 56 | 东诚药业 | 4.28% | 5.56% | 6.6分 |
| 58 | 双鹭药业 | 4.01% | 0.94% | 5.4分 |
| 60 | - | 3.98% | 5.28% | 分 |
| 62 | 川宁生物 | 3.75% | 0.80% | 5.3分 |
| 64 | 华北制药 | 3.70% | 3.88% | 6.4分 |
| 66 | 共同药业 | 3.19% | 3.19% | 5.3分 |
| 68 | 舒泰神 | 3.03% | 8.77% | 5.1分 |
| 70 | 哈药股份 | 2.50% | 1.37% | 5.7分 |
| 72 | 华润双鹤 | 2.44% | 0.78% | 6.3分 |
| 74 | 天新药业 | 2.31% | 2.04% | 5.7分 |
| 76 | 仟源医药 | 1.89% | -1.55% | 5.4分 |
| 78 | 东北制药 | 1.65% | 1.65% | 5.4分 |
| 80 | 新华制药 | 1.21% | 2.06% | 5.5分 |
| 82 | 中关村 | 1.14% | 4.12% | 5.7分 |
| 84 | 奥锐特 | 1.01% | 0.66% | 6.4分 |
| 86 | 宣泰医药 | 0.65% | -0.19% | 5.5分 |
| 88 | 北陆药业 | 0.12% | 0.58% | 5.3分 |
| 90 | - | 0.05% | -0.18% | 分 |
| 92 | 国邦医药 | -0.53% | 0.40% | 5.8分 |
| 94 | 千红制药 | -0.55% | 2.37% | 5.9分 |
| 96 | 汇宇制药 | -1.22% | 3.90% | 6.0分 |
| 98 | 键凯科技 | -1.38% | 0.97% | 6.2分 |
| 100 | 新和成 | -1.57% | 0.74% | 6.2分 |
| 102 | 国药现代 | -2.25% | 0.10% | 5.4分 |
| 104 | 仙琚制药 | -2.66% | 1.60% | 5.5分 |
| 106 | 圣诺生物 | -3.04% | 3.04% | 6.6分 |
| 108 | 卫信康 | -3.19% | 2.56% | 5.8分 |
| 110 | 健康元 | -3.59% | 1.85% | 5.7分 |
| 112 | 北大医药 | -3.76% | 2.44% | 5.8分 |
| 114 | 健友股份 | -4.12% | 0.50% | 6.2分 |
| 116 | 复星医药 | -4.52% | -0.04% | 5.5分 |
| 118 | 花园生物 | -4.76% | 0.07% | 5.3分 |
| 120 | 艾力斯 | -4.82% | -3.27% | 5.6分 |
| 122 | 奥赛康 | -5.40% | 3.30% | 5.8分 |
| 124 | 悦康药业 | -5.78% | 0.49% | 5.6分 |
| 126 | 金城医药 | -6.51% | 2.56% | 5.3分 |
| 128 | 泽璟制药 | -6.87% | 11.01% | 5.9分 |
| 130 | 诚意药业 | -6.90% | 0.69% | 5.6分 |
| 132 | 力生制药 | -7.13% | -0.37% | 5.2分 |
| 134 | 亚虹医药 | -7.28% | -1.11% | 5.0分 |
| 136 | 首药控股 | -8.52% | 5.26% | 5.9分 |
| 138 | 吉贝尔 | -9.04% | -1.73% | 5.9分 |
| 140 | 海创药业 | -9.54% | -10.94% | 5.0分 |
| 142 | 京新药业 | -10.50% | 3.12% | 6.0分 |
| 144 | 一品红 | -11.44% | -2.02% | 5.0分 |
| 146 | 恒瑞医药 | -12.27% | -0.73% | 6.2分 |
| 148 | 迪哲医药 | -12.51% | 3.18% | 6.0分 |
| 150 | 华纳药厂 | -14.53% | -1.62% | 5.2分 |
| 152 | 盟科药业 | -21.53% | -2.45% | 5.1分 |
| 154 | 必贝特 | - | -7.73% | 3.6分 |
| 156 | 河化股份 | - | 3.58% | 6.7分 |
| 158 | 金陵药业 | - | 0.97% | 6.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/219 ， 126/219。
[{"date":"2025-09-30","value":"10.59","vol":"1.45"},{"date":"2025-06-30","value":"8.35","vol":"1.21"},{"date":"2025-03-31","value":"3.62","vol":"-0.17"},{"date":"2024-12-31","value":"15.91","vol":"19.51"},{"date":"2024-09-30","value":"13.59","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
10.59 | 8.35 | 3.62 | 15.91 | 13.59 |
| 行业(%) | 1.45 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"25.02","vol":"49.21"},{"date":"2025-06-30","value":"25.73","vol":"49.43"},{"date":"2025-03-31","value":"24.02","vol":"49.23"},{"date":"2024-12-31","value":"23.85","vol":"50.77"},{"date":"2024-09-30","value":"24.23","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
25.02 | 25.73 | 24.02 | 23.85 | 24.23 |
| 行业(%) | 49.21 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 123/219 ， 95/219。
[{"date":"2025-09-30","value":"-16.43","vol":"142.42"},{"date":"2025-06-30","value":"-15.31","vol":"78.53"},{"date":"2025-03-31","value":"-14.63","vol":"-0.84"},{"date":"2024-12-31","value":"4.77","vol":"17.76"},{"date":"2024-09-30","value":"9.30","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.43 | -15.31 | -14.63 | 4.77 | 9.30 |
| 行业(%) | 142.42 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-19.48","vol":"-6.13"},{"date":"2025-06-30","value":"-9.89","vol":"56.29"},{"date":"2025-03-31","value":"1.98","vol":"-21.21"},{"date":"2024-12-31","value":"-2.29","vol":"-20.55"},{"date":"2024-09-30","value":"2.15","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-19.48 | -9.89 | 1.98 | -2.29 | 2.15 |
| 行业(%) | -6.13 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/219 ， 22/219。
[{"date":"2025-09-30","value":"0.63","vol":"0.30"},{"date":"2025-06-30","value":"0.43","vol":"0.21"},{"date":"2025-03-31","value":"0.21","vol":"0.10"},{"date":"2024-12-31","value":"0.94","vol":"0.43"},{"date":"2024-09-30","value":"0.71","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.63 | 0.43 | 0.21 | 0.94 | 0.71 |
| 行业(次) | 0.30 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.36","vol":"1.96"},{"date":"2025-06-30","value":"2.28","vol":"1.31"},{"date":"2025-03-31","value":"1.18","vol":"0.67"},{"date":"2024-12-31","value":"4.64","vol":"3.22"},{"date":"2024-09-30","value":"3.58","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.36 | 2.28 | 1.18 | 4.64 | 3.58 |
| 行业(次) | 1.96 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"15.82","vol":"4.21"},{"date":"2025-06-30","value":"15.55","vol":"2.81"},{"date":"2025-03-31","value":"-0.55","vol":"-28.76"},{"date":"2024-12-31","value":"1.58","vol":"-371.46"},{"date":"2024-09-30","value":"6.46","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 15.82 | 15.55 | -0.55 | 1.58 | 6.46 |
| 行业 | 4.21 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.50","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.79","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.50 | - | 0.79 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 43/219 ， 7/219。
[{"date":"2025-09-30","value":"1.43","vol":"3.50"},{"date":"2025-06-30","value":"1.49","vol":"3.67"},{"date":"2025-03-31","value":"1.51","vol":"3.59"},{"date":"2024-12-31","value":"1.43","vol":"3.34"},{"date":"2024-09-30","value":"1.36","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.43 | 1.49 | 1.51 | 1.43 | 1.36 |
| 行业 | 3.50 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.07","vol":"2.74"},{"date":"2025-06-30","value":"1.10","vol":"2.89"},{"date":"2025-03-31","value":"1.12","vol":"2.81"},{"date":"2024-12-31","value":"1.05","vol":"2.64"},{"date":"2024-09-30","value":"0.97","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.07 | 1.10 | 1.12 | 1.05 | 0.97 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 16/219 ， 41/219。
[{"date":"2025-09-30","value":"46.34","vol":"33.67"},{"date":"2025-06-30","value":"45.88","vol":"33.79"},{"date":"2025-03-31","value":"44.93","vol":"34.04"},{"date":"2024-12-31","value":"46.97","vol":"34.19"},{"date":"2024-09-30","value":"50.61","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
46.34 | 45.88 | 44.93 | 46.97 | 50.61 |
| 行业(%) | 33.67 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.86","vol":"0.94"},{"date":"2025-06-30","value":"0.85","vol":"0.88"},{"date":"2025-03-31","value":"0.82","vol":"1.46"},{"date":"2024-12-31","value":"0.89","vol":"0.84"},{"date":"2024-09-30","value":"1.03","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.86 | 0.85 | 0.82 | 0.89 | 1.03 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 西部证券 | 2025-11-03 | 买入 | 买入 |
| 招商证券 | 2025-10-28 | 买入 | 买入 |
| 中泰证券 | 2025-10-24 | 买入 | 买入 |
| 开源证券 | 2025-10-23 | 买入 | 买入 |
| 太平洋 | 2025-10-21 | 买入 | 买入 |
| 兴业证券 | 2025-08-23 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"9.56","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"9.89","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"10.55","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.31","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.96","blueLineValue":"0.86","type":"YC"}]